Search
FDA Daily Update
08/19/2019The following is a summary of U.S. Food and Drug Administration (FDA) activities for today: FDA approves new antibiotic to treat co...
- Food and Drug Administration
- All Healthcare Organizations
OIG Workplan – August 2019 Update
08/16/2019The Office of Inspector General (OIG) released its August 2019 Workplan update. Below is a selection of update topics of interest to hospitals an...
- Office of Inspector General
- All Healthcare Organizations
Pfizer Inc. is voluntarily recalling RELPAX® (eletriptan hydrobromide) 40 mg tablets, lots AR5407 and CD4565, to the Patient level. Pfizer I...
- Food and Drug Administration
- All Healthcare Organizations
The U.S. Department of Health and Human Services, Office for Civil Rights (HHS OCR), has entered into a voluntary resolution agreement with Michi...
- Department of Health and Human Services
- All Healthcare Organizations
A U.S. Food and Drug Administration (FDA) review of additional data has found no increased risk of prostate cancer with the use of entacapone to ...
- Food and Drug Administration
- All Healthcare Organizations
Safe + Sound Week
08/12/2019Safe + Sound Week is a nationwide event held each August that recognizes the successes of workplace safety and health programs and offers informa...
- Occupational Safety and Health Administration
- All Healthcare Organizations
Class I Recall of Fresenius Kabi Volumat MC Agilia Infusion Pump and Vigilant Agilia Drug Library
08/12/2019Fresenius Kabi is recalling their Volumat MC Agilia Infusion Pump and Vigilant Agilia Drug Library due to a "Low Priority" "Keep Vein Open (KVO)...
- Food and Drug Administration
- All Healthcare Organizations
Injection Safety
08/09/2019According to the U.S. Center Disease Control and Prevention (CDC), unsafe injection practices put patients and healthcare providers at risk of in...
- Centers for Disease Control and Prevention
- All Healthcare Organizations
FDA Encourages Continued Submission of Reports Related to Seizures following E-cigarette Use
08/08/2019The U.S. Food and Drug Administration (FDA) is continuing its scientific investigation to determine if there’s a direct relationship betwee...
- Food and Drug Administration
- All Healthcare Organizations
According to the U.S. Centers for Disease Control and Prevention (CDC) there is wide variation in prescribing and dispensing Naloxone persists ac...
- Centers for Disease Control and Prevention
- All Healthcare Organizations
The US Centers for Disease Control and Prevention (CDC) has recently released interim infection prevention and control recommendations for measle...
- Centers for Disease Control and Prevention
- All Healthcare Organizations
Earlier this year, the U.S. Food and Drug Administration (FDA) notified health care providers about a late mortality signal in patients treated f...
- Food and Drug Administration
- All Healthcare Organizations
Abbott is recalling the Ellipse Implantable Cardioverter Defibrillators (ICDs) because electrical failures have been identified and determined to...
- Food and Drug Administration
- All Healthcare Organizations
The U.S. Centers for Medicare and Medicaid Services (CMS) recently updated their memorandum on Immediate Jeopardy, reinserting language to Append...
- Centers for Medicare and Medicaid Services
- Critical Access Hospitals,
- Hospitals,
- Long Term Care,
- Clinical Lab
Class I Recall of QIAGEN Filter Tips
08/05/2019The U.S. Food and Drug Administration (FDA) has announced a Class I recall of QIAGEN filter tips for use with the QIAsymphony SP/AS instruments d...
- Food and Drug Administration
- All Healthcare Organizations